Our top pick for
Fossil Group Inc is a luxury goods business based in the US. Fossil Group shares (FOSL) are listed on the NASDAQ and all prices are listed in US Dollars. Fossil Group employs 7,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$11.78|
|52-week range||$5.63 - $19.52|
|50-day moving average||$12.44|
|200-day moving average||$12.95|
|Wall St. target price||$7.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.27|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-5.46%|
|1 month (2021-09-24)||-11.83%|
|3 months (2021-07-23)||-5.99%|
|6 months (2021-04-23)||-6.73%|
|1 year (2020-10-23)||93.75%|
|2 years (2019-10-23)||-2.64%|
|3 years (2018-10-23)||19.76|
|5 years (2016-10-21)||28.4|
Valuing Fossil Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fossil Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fossil Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $116.5 million.
The EBITDA is a measure of a Fossil Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.7 billion|
|Operating margin TTM||4.6%|
|Gross profit TTM||$770.4 million|
|Return on assets TTM||3.58%|
|Return on equity TTM||-3.14%|
|Market capitalisation||$614.3 million|
TTM: trailing 12 months
There are currently 4.9 million Fossil Group shares held short by investors – that's known as Fossil Group's "short interest". This figure is 3.1% down from 5.0 million last month.
There are a few different ways that this level of interest in shorting Fossil Group shares can be evaluated.
Fossil Group's "short interest ratio" (SIR) is the quantity of Fossil Group shares currently shorted divided by the average quantity of Fossil Group shares traded daily (recently around 405625.91973244). Fossil Group's SIR currently stands at 11.96. In other words for every 100,000 Fossil Group shares traded daily on the market, roughly 11960 shares are currently held short.
However Fossil Group's short interest can also be evaluated against the total number of Fossil Group shares, or, against the total number of tradable Fossil Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fossil Group's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Fossil Group shares in existence, roughly 90 shares are currently held short) or 0.1475% of the tradable shares (for every 100,000 tradable Fossil Group shares, roughly 148 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Fossil Group.
Find out more about how you can short Fossil Group stock.
We're not expecting Fossil Group to pay a dividend over the next 12 months.
Fossil Group's shares were split on a 3:2 basis on 11 April 2004. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Fossil Group shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Fossil Group shares which in turn could have impacted Fossil Group's share price.
Over the last 12 months, Fossil Group's shares have ranged in value from as little as $5.63 up to $19.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fossil Group's is 1.8746. This would suggest that Fossil Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Fossil Group, Inc. , together with its subsidiaries, designs, develops, markets, and distributes consumer fashion accessories in the United States, Europe, Asia, and internationally. The company's products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts, and sunglasses. It also manufactures and distributes private label brands, as well as purchases and resells branded products in non-FOSSIL branded retail stores. The company offers its products under its proprietary brands, such as FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC; and under the licensed brands, including ARMANI EXCHANGE, DIESEL, DKNY, EMPORIO ARMANI, KATE SPADE NEW YORK, MICHAEL KORS, PUMA, TORY BURCH, Skechers, and BMW. The company sells its products through company-owned retail and outlet stores, department stores, specialty retail stores, specialty watch and jewelry stores, mass market stores, e-commerce sites, licensed and franchised FOSSIL retail stores, and retail concessions, as well as sells its products on airlines and cruise ships. As of January 2, 2021, it operated 421 stores worldwide.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.